Comparing antimicrobial susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin using MicroScan® (Pos Combo 3.1J) and conventional methods

International Journal of Antimicrobial Agents

Volumn 36, Issue 3, 2010, Pages 291-293

  Nakashima, Hanae ^a   Kameko, Mitsuaki ^a   Takahashi, Hiroshi ^b   Saito, Hiroshi ^b  

^a Nagano Municipal Hospital   (Japan)

^b Nagano Prefectural Suzaka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; INTERMETHOD COMPARISON; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; COMPARATIVE STUDY; DRUG EFFECTS; EVALUATION STUDY; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; JAPAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; HOSPITALS; HUMANS; JAPAN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 77954952012     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.05.010     Document Type: Letter

References (7)

1. Hsu D.I., Hidayat L.K., Quist R., Hindler J., Karlsson A., Yusof A., et al. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 2008, 32:378-385.
2. Prakash V., Lewis J.S., Jorgensen J.H. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother 2008, 52:4528.
3. Sader H.S., Rhomberg P.R., Jones R.N. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009, 53:3162-3165.
4. Lodise T.P., Graves J., Evans A., Graffunder E., Helmecke M., Lomaestro B.M., et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008, 52:3315-3320.
5. Japanese Association of Medical Technologists. Clinical control report 2008, Microbiology. JAMT; January 2009.
6. Rybak M., Lomaestro B., Rotschafer J.C., Moellering R., Craig W., Billeter M., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Disease Pharmacists. Am J Health Syst Pharm 2009, 66:82-98. [Erratum in: Am J Health Syst Pharm 2009;66:887].
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009.